Kesol

Budesonide, the active ingredient in Kesol, is a corticosteroid (glucocorticoid) presented as a nasal spray for nasal use. It is indicated for the treatment of allergic rhinitis, including seasonal and perennial forms, as well as for managing nasal polyps in both adults and children.

GNH USA supplies Kesol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics across multiple markets, and supporting patient care through dedicated technical assistance and supply chain transparency.

Kesol, a nasal corticosteroid, acts on inflammatory processes of the nasal mucosa to relieve symptoms of allergic conditions.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. Seasonal allergic rhinitis: provides symptom relief during pollen seasons. Perennial allergic rhinitis: controls year‑round nasal inflammation. Nasal polyps: helps shrink polyps and improve nasal airflow.

Common and serious adverse reactions have been reported with nasal budesonide use.

Common Side Effects: - Nasal irritation or burning - Epistaxis (nosebleeds) - Headache - Throat irritation or dryness - Altered taste sensation

Serious or Rare Side Effects: - Fungal infection of the nasal mucosa (e.g., Candida) - Severe or persistent nosebleeds - Vision changes or cataract formation - Adrenal suppression with extensive use - Hypersensitivity reactions including angioedema

Before prescribing Kesol, consider the following precautions to ensure safe use.

Pregnancy: safety not established; use only if potential benefit justifies risk. Breastfeeding: assess risk versus benefit; budesonide may be present in milk. Concomitant use with strong CYP3A4 inhibitors: may increase systemic exposure. Long‑term therapy: monitor for signs of adrenal suppression or ocular effects. Nasal surgery or trauma: avoid or use with caution until healing is complete. Store at room temperature: keep in original container, protect from moisture and heat.

Kesol may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise budesonide levels. - Live vaccines: reduced efficacy due to immunosuppression.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (e.g., erythromycin, fluconazole): may modestly increase exposure. - Ritonavir: may increase systemic budesonide concentrations. - Antifungal azoles (posaconazole): monitor for enhanced effects.